Betamethasone Sodium Phosphate Injection
» Betamethasone Sodium Phosphate Injection is a sterile solution of Betamethasone Sodium Phosphate in Water for Injection. It contains an amount of betamethasone sodium phosphate (C22H28FNa2O8P) equivalent to not less than 90.0 percent and not more than 110.0 percent of the labeled amount of betamethasone (C22H29FO5).
Packaging and storage—
Preserve in single-dose or in multiple-dose containers, preferably of Type I glass.
Identification—
Dilute the Injection with methanol, if necessary, to obtain a solution containing about 2 mg of betamethasone sodium phosphate per mL. Separately apply 10 µL of this test solution and 10 µL of a solution of USP Betamethasone Sodium Phosphate RS in methanol containing 2 mg per mL to a thin-layer chromatographic plate (see Chromatography 
621
) coated with chromatographic silica gel mixture. Develop the chromatogram in an equilibrated chamber containing n-butyl alcohol previously shaken with 1 N hydrochloric acid, until the solvent front has moved about three-fourths of the length of the plate. Remove the plate from the developing chamber, air-dry, then spray with a mixture of sulfuric acid, methanol, and nitric acid (10:10:1). Heat the plate at 105
for 10 minutes: the RF value of the principal spot from the test solution corresponds to that obtained from the Standard solution.
621) coated with chromatographic silica gel mixture. Develop the chromatogram in an equilibrated chamber containing n-butyl alcohol previously shaken with 1 N hydrochloric acid, until the solvent front has moved about three-fourths of the length of the plate. Remove the plate from the developing chamber, air-dry, then spray with a mixture of sulfuric acid, methanol, and nitric acid (10:10:1). Heat the plate at 105 for 10 minutes: the RF value of the principal spot from the test solution corresponds to that obtained from the Standard solution.
Bacterial endotoxins 85—
It contains not more than 29.2 USP Endotoxin Units per mg of betamethasone.
85—
It contains not more than 29.2 USP Endotoxin Units per mg of betamethasone.
pH 791:
between 8.0 and 9.0.
791:
between 8.0 and 9.0.
Particulate matter 788:
meets the requirements for small-volume injections.
788:
meets the requirements for small-volume injections.
Other requirements—
It meets the requirements under Injections 1.
1.
Assay—
Mobile phase—
Prepare a filtered and degassed mixture of methanol and 0.05 M monobasic potassium phosphate (1:1). Make adjustments if necessary (see System Suitability under Chromatography 621).
621).
Internal standard solution—
Transfer about 100 mg of butylparaben to a 100-mL volumetric flask, add methanol to volume, and mix.
Standard preparation—
Using an accurately weighed quantity of USP Betamethasone Sodium Phosphate RS, prepare a solution in water containing 4 mg per mL. Transfer 3.0 mL of this solution to a 25-mL volumetric flask, add 5.0 mL of Internal standard solution, dilute with water to volume, and mix to obtain a solution having a known concentration of about 0.5 mg of USP Betamethasone Sodium Phosphate RS per mL.
Assay preparation—
Transfer an accurately measured volume of Injection, equivalent to about 9 mg of betamethasone, to a 25-mL volumetric flask. Add 5.0 mL of the Internal standard solution, dilute with water to volume, and mix.
Chromatographic system
(see Chromatography 621)—The liquid chromatograph is equipped with a 254-nm detector and a 3.9-mm × 30-cm column that contains packing L1. The flow rate is about 2 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the resolution, R, between the analyte and internal standard peaks is not less than 5; and the relative standard deviation for replicate injections is not more than 2.0%.
621)—The liquid chromatograph is equipped with a 254-nm detector and a 3.9-mm × 30-cm column that contains packing L1. The flow rate is about 2 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the resolution, R, between the analyte and internal standard peaks is not less than 5; and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure—
Separately inject equal volumes (about 20 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. The relative retention times are about 2.4 for butylparaben and 1.0 for betamethasone sodium phosphate. Calculate the quantity, in mg, of C22H29FO5 in each mL of the Injection taken by the formula:
(392.47 / 516.41)(25C / V)(RU / RS)
in which 392.47 and 516.41 are the molecular weights of betamethasone and betamethasone sodium phosphate, respectively; C is the concentration, in mg per mL, of USP Betamethasone Sodium Phosphate RS in the Standard preparation; V is the volume, in mL, of Injection taken; and RU and RS are the peak response ratios obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information—
Please check for your question in the FAQs before contacting USP.
Chromatographic Column—
| Topic/Question | Contact | Expert Committee |
| Monograph | Daniel K. Bempong, Ph.D.
Senior Scientist 1-301-816-8143 |
(MDPS05) Monograph Development-Pulmonary and Steroids |
| Reference Standards | Lili Wang, Technical Services Scientist 1-301-816-8129 RSTech@usp.org |
|
| 85 |
Radhakrishna S Tirumalai, Ph.D.
Senior Scientist 1-301-816-8339 |
(MSA05) Microbiology and Sterility Assurance |
USP32–NF27 Page 1663
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.